ROSETTA GENOMICS LTD. WAIVER May 8, 2017Waiver • May 15th, 2017 • Rosetta Genomics Ltd. • Pharmaceutical preparations
This Waiver is made by and among Rosetta Genomics Ltd, an Israeli corporation (the “Company”), and each Purchaser that is a party to (i) that certain Securities Purchase Agreement, dated November 23, 2016, by and between the Company and each such Purchaser (the “Purchase Agreement”) and (ii) that certain Registration Rights Agreement, dated November 23, 2016, by and between the Company and each such Purchaser (the “RRA”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Purchase Agreement or the RRA, as applicable.
